Ranbaxy Laboratories Ltd., the India-based generic-drug maker beset by manufacturing-quality problems, has issued another recall of generic versions of the cholesterol drug Lipitor in the U.S. due to a potential dose mix-up.
Read the whole story at Wall Street Journal